Recombinant Callicebus moloch F-actin-capping protein subunit alpha-2 (CAPZA2)

How does CAPZA2 contribute to cellular functions beyond actin regulation?

CAPZA2 plays multiple roles beyond simple actin regulation. In muscle tissues, it participates in organizing myofilaments during myofibrillogenesis and is present at Z-discs, contributing to the polarity and organization of sarcomeric actin. Additionally, CAPZA2 modulates intracellular signaling in cardiac muscle by affecting the activity of protein phosphatase 1 (PP1) on myofilament proteins.

Research has shown CAPZA2 expression is upregulated in response to muscle damage, suggesting a role in muscle growth and remodeling. Furthermore, variants in CAPZA2 have been associated with neurological symptoms such as developmental delay and seizures, indicating its importance in neurological functions. These diverse roles make CAPZA2 a significant protein for understanding both cytoskeletal dynamics and broader cellular processes.

What expression systems are most effective for producing recombinant Callicebus moloch CAPZA2 protein?

When selecting an expression system, researchers should consider: (1) required protein folding and post-translational modifications, (2) downstream applications, (3) required purity level, and (4) available resources for protein production and purification .

What are the critical methodological considerations when designing experiments to study CAPZA2 interactions with actin filaments?

When designing experiments to study CAPZA2-actin interactions, researchers should consider several critical factors:

• Protein preparation: Ensure both CAPZA2 and actin preparations maintain native conformations. For CAPZA2, the C-terminal region contains critical residues for actin binding, including three regularly spaced leucines, which must remain intact.

• Heterodimer formation: CAPZA2 functions as a heterodimer with a beta subunit. Experiments should account for this by either co-expressing both subunits or reconstituting the complex in vitro.

• Actin dynamics assessment: Methods such as pyrene-labeled actin assays, total internal reflection fluorescence (TIRF) microscopy, or fluorescence recovery after photobleaching (FRAP) can effectively monitor how CAPZA2 affects actin polymerization and depolymerization rates.

• Structural analysis: Techniques like X-ray crystallography or cryo-electron microscopy can provide insights into the binding interface between CAPZA2 and actin filaments.

• Physiological conditions: Experiments should replicate physiological pH, salt concentrations, and temperature to ensure relevance.

When interpreting results, researchers should consider that CAPZA2 is 85% identical to CAPZA1, with 21 amino acid differences contributing to isoform specificity, which might affect experimental outcomes.

How does Callicebus moloch CAPZA2 compare structurally and functionally to CAPZA2 from other primate species?

Comparative analysis of CAPZA2 across primate species reveals both conservation and species-specific variations:

The sequence analysis shows that while the core functional domains of CAPZA2 are highly conserved across primates, subtle species-specific variations exist, particularly in regions that may influence actin-binding specificity or interaction with regulatory proteins .

These differences may reflect evolutionary adaptations related to species-specific cytoskeletal requirements. For example, comparing the available sequences of Callicebus moloch and Microcebus murinus CAPZA2, we observe conservation in the actin-binding regions but subtle differences in potential regulatory sites, which may affect how these proteins respond to cellular signaling .

What are the evolutionary implications of CAPZA2 conservation and variation among New World Monkeys?

The evolutionary conservation of CAPZA2 among New World Monkeys (NWMs) provides insights into both cytoskeletal protein evolution and primate phylogeny. CAPZA2 appears at evolutionary conserved breakpoints (ECBs), which are chromosomal regions that have undergone rearrangements during evolution .

Analysis of ECBs in NWMs, including Callicebus moloch, Alouatta caraya (ACA), Cebus apella (CAP), Callithrix jacchus (CJA), and Saimiri sciureus (SSC), reveals that CAPZA2 is located in regions that correspond to fragile sites (FSs) in the human genome. Specifically, these ECBs often co-localize with known FSs (more than 60%) and correspond to breakpoints observed in human disorders (approximately 70%) .

How can recombinant CAPZA2 be utilized to investigate cytoskeletal dynamics in neurological disorders?

Recombinant CAPZA2 provides a valuable tool for investigating cytoskeletal dynamics in neurological disorders through several sophisticated approaches:

• In vitro neuronal cytoskeleton models: Recombinant CAPZA2 can be used to reconstitute actin regulation in controlled environments, allowing researchers to study how CAPZA2 variants associated with neurological disorders (such as developmental delay and seizures) affect actin dynamics differently from wild-type protein.

• Live-cell imaging studies: Tagged recombinant CAPZA2 can be introduced into neuronal cultures to track its localization and dynamics during neuronal development, migration, and synapse formation using advanced microscopy techniques.

• Protein-protein interaction screens: Immobilized recombinant CAPZA2 can serve as bait in pull-down assays to identify neuronal-specific binding partners, potentially revealing mechanisms underlying its role in neurological disorders.

• Disease-specific mutations: CRISPR-engineered cellular models expressing CAPZA2 with disease-associated mutations can be compared with cells complemented with recombinant wild-type CAPZA2 to elucidate pathogenic mechanisms.

• Biomechanical studies: Atomic force microscopy combined with recombinant CAPZA2 can assess how this protein affects the mechanical properties of actin networks in neuronal growth cones and dendritic spines.

These approaches can help determine how CAPZA2 dysfunction contributes to neuronal pathology, potentially leading to therapeutic strategies targeting cytoskeletal regulation.

What is the relationship between CAPZA2 and evolutionary conserved breakpoints (ECBs) in primate genomics?

The relationship between CAPZA2 and evolutionary conserved breakpoints (ECBs) represents an advanced research area bridging cytoskeletal biology and comparative genomics. Research has identified that CAPZA2 is located in genomic regions corresponding to ECBs in various primate species .

ECBs represent chromosomal regions that have undergone rearrangements during evolution. Studies comparing Old World Monkeys (OWMs) and New World Monkeys (NWMs), including Callicebus moloch, have revealed numerous ECBs. Specifically, researchers have identified:

• 73 ECBs in Trachypithecus cristatus (TCR)

• 53 identical ECBs for all studied macaque species

• 41 in Chlorocebus aethiops (CAE)

• 51 in Alouatta caraya (ACA)

• 44 in Cebus apella (CAP)

• 47 in Callithrix jacchus (CJA)

• 64 in Saimiri sciureus (SSC)

Most significantly, more than 60% of these ECBs co-localize with known fragile sites (FSs) observed in the human genome, and approximately 70% correspond to breakpoints observed in human disorders. This suggests that CAPZA2, located within these regions, may have evolutionary significance beyond its cytoskeletal functions .

Advanced genomic approaches such as array-comparative genomic hybridization (aCGH) have enabled more precise characterization of these ECBs, allowing researchers to investigate how CAPZA2 genomic organization has evolved across primate lineages and potentially contributed to species-specific adaptations .

What strategies can overcome common challenges in producing and purifying functional recombinant CAPZA2?

Researchers may encounter several challenges when producing and purifying functional recombinant CAPZA2. Here are evidence-based strategies to address these issues:

• Protein solubility issues:

  • Optimize expression temperature (typically lowering to 16-18°C)

  • Use solubility-enhancing fusion tags (SUMO or GST tags can improve CAPZA2 solubility)

  • Adjust induction conditions (IPTG concentration and induction timing)

  • Include stabilizing agents (such as glycerol, arginine, or low concentrations of non-ionic detergents) in buffers

• Maintaining functional activity:

  • Co-express with beta subunit to form the native heterodimeric complex

  • Ensure proper folding by including molecular chaperones in expression systems

  • Avoid harsh elution conditions during purification

  • Validate activity using actin polymerization assays post-purification

• Purification optimization:

  • For His-tagged CAPZA2, use immobilized metal affinity chromatography with gradient elution

  • Include a secondary purification step such as size exclusion chromatography

  • Optimize buffer conditions to maintain protein stability and prevent aggregation

  • Consider on-column refolding protocols if inclusion bodies form

• Quality control assessments:

  • Confirm protein identity via mass spectrometry

  • Assess purity using SDS-PAGE (aim for >90% purity)

  • Verify proper folding using circular dichroism

  • Evaluate oligomeric state using size exclusion chromatography or analytical ultracentrifugation

These approaches should be adapted based on the specific expression system used (yeast, E. coli, or mammalian cells) and the intended downstream applications.

How can researchers effectively design experiments to investigate CAPZA2 interactions with other cytoskeletal regulatory proteins?

Designing experiments to investigate CAPZA2 interactions with other cytoskeletal regulatory proteins requires careful consideration of multiple factors:

• Protein-protein interaction screening:

  • Yeast two-hybrid assays can identify novel CAPZA2 binding partners

  • Co-immunoprecipitation using recombinant tagged CAPZA2 can validate interactions

  • Proximity labeling methods (BioID or APEX) can identify spatial neighbors of CAPZA2

  • Surface plasmon resonance or microscale thermophoresis can determine binding kinetics and affinities

• Functional validation approaches:

  • In vitro reconstitution assays using purified components

  • FRET-based assays to monitor protein-protein interactions in real-time

  • Competition assays to determine binding sites and specificity

  • Mutagenesis studies targeting key residues identified in structural analyses

• Structural characterization:

  • Cross-linking mass spectrometry to map interaction interfaces

  • Hydrogen-deuterium exchange mass spectrometry to identify conformational changes

  • Cryo-electron microscopy for large complexes

  • X-ray crystallography for high-resolution structures of complexes

• Cellular context considerations:

  • Use cell types where CAPZA2 naturally functions (e.g., muscle cells for studying Z-disc interactions)

  • Create cellular knockdown/knockout models with rescue using mutant variants

  • Employ live-cell imaging with fluorescently tagged proteins to track dynamics

  • Consider tissue-specific interacting partners that may be absent in common model systems

When analyzing results, researchers should account for the potential influence of tags, expression levels, and cellular context on interaction dynamics. Validation across multiple techniques strengthens confidence in identified interactions and provides complementary information about functional significance.

What are the implications of CAPZA2 in evolutionary studies of primates and its potential as a phylogenetic marker?

CAPZA2's location within evolutionary conserved breakpoints (ECBs) positions it as a valuable target for evolutionary studies of primates. Research has demonstrated that chromosomal regions containing CAPZA2 have undergone significant rearrangements during primate evolution, particularly in monkey chromosomes homologous to human chromosomes #3, #7, and #9, which show enhanced rates of ECBs in both Old World Monkeys (OWMs) and New World Monkeys (NWMs) .

The analysis of CAPZA2 genomic organization across primate species can provide insights into:

• Primate phylogenetic relationships: Comparing CAPZA2 genomic contexts across species can help resolve phylogenetic relationships, particularly among closely related species where traditional markers may be insufficient.

• Chromosomal evolution rates: The variable conservation of CAPZA2-containing regions across different primate lineages can serve as an indicator of chromosomal evolution rates.

• Functional constraints: The degree of conservation of CAPZA2 sequence and structure across species reflects the functional constraints on this protein through evolutionary time.

• Speciation events: Changes in CAPZA2 genomic organization may correlate with speciation events in primate evolution.

Advanced molecular cytogenetic techniques, such as fluorescence in situ hybridization (FISH) and array-comparative genomic hybridization (aCGH), can be employed to track CAPZA2 across primate genomes, potentially revealing patterns of chromosomal evolution not evident from sequence data alone .

How can advanced structural biology approaches enhance our understanding of CAPZA2's actin-capping mechanism?

Advanced structural biology approaches offer unprecedented opportunities to elucidate CAPZA2's actin-capping mechanism at atomic resolution:

• Cryo-electron microscopy (cryo-EM): This technique can capture the CAPZA2-beta heterodimer bound to actin filaments in near-native conditions, revealing dynamic conformational states that may not be accessible through crystallography. Recent advances in cryo-EM resolution now enable visualization of side-chain interactions at the binding interface.

• Integrative structural biology: Combining multiple structural techniques (X-ray crystallography, NMR, small-angle X-ray scattering) with computational modeling can provide a more complete picture of the capping mechanism, including conformational changes upon binding.

• Time-resolved structural studies: Emerging techniques like time-resolved cryo-EM or X-ray free-electron laser crystallography can capture intermediate states during CAPZA2 binding to actin, revealing the kinetic pathway of capping.

• Molecular dynamics simulations: Based on structural data, simulations can model the energetics and dynamics of CAPZA2-actin interactions, predicting how specific amino acid substitutions might affect binding affinity and specificity.

• In-cell structural biology: Techniques like in-cell NMR or correlative light and electron microscopy can study CAPZA2 structure in cellular contexts, accounting for the influence of cellular factors on its conformation and function.

These approaches will help identify critical residues involved in actin recognition, elucidate the conformational changes that occur upon binding, and potentially reveal species-specific adaptations in the CAPZA2 structure that optimize its function in different primate lineages. This information could lead to the development of specific inhibitors or engineered variants with enhanced or altered activities for research applications .